HSA Approval

APO-GLICLAZIDE TABLET 80MG

Approval Number

SIN13468P

Drug Name

Product Name

APO-GLICLAZIDE TABLET 80MG

Approval Date

May 15, 2008

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

A10BB09

ATC Item Name

gliclazide

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC.(150 SIGNET)

Active Ingredients

Ingredient Name

GLICLAZIDE

Strength

80 mg

Drug MonographGliclazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APO-GLICLAZIDE TABLET 80MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-GLICLAZIDE TABLET 80MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal